Drug Manufacturers

COVID-19 vaccine boosters could mean billions for drugmakers

For Pfizer and Moderna, the boosters could be more profitable than the original doses because they won’t come with the R&D costs

26 Sep 2021 10:48 AM

The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes

17 Jul 2021 12:53 PM

Samsung BioLogics reported a 1.9 trillion won (USD 1.77 billion) net profit in 2015.

02 May 2018 12:23 PM

Experiments with 20 ant species found antimicrobials on 12 of them, a team reported in the Royal Society Open Science journal.

07 Feb 2018 8:18 AM

1 of 1

Baba Ramdev's Apology: Too Little, Too Late for His Alleged Frauds

Preserving Literature or Perpetuating Censorship? The Debate Over Revisionism in Academic Circles

Economic woes, agrarian discontent, and regional dynamics may pose hurdles for BJP's electoral prospects.

The Middle East conflict is complex, with Iran and Israel adopting strategies to neutralize each other